Shiseido, the leading Japanese beauty company, has recently announced that its subsidiary in the Americas has signed a definitive agreement to acquire DDG Skincare Holdings, the parent company of Dr Dennis Gross Skincare. Although the financial terms of the deal have not been disclosed, this acquisition is touted as a “highly strategic transaction” for Shiseido.

Dr Dennis Gross Skincare is a prestigious brand known for its dermatologist-led, science-based approach to skincare. The brand is credited with revolutionizing the beauty industry by offering high-quality products that harness the power of active ingredients with proven skincare benefits. With its focus on innovation, the acquisition of Dr Dennis Gross Skincare aligns perfectly with Shiseido’s corporate mission.

By bringing Dr Dennis Gross Skincare under its umbrella, Shiseido aims to strengthen its skin beauty strategic framework and expand its global portfolio of prestigious brands, which already includes renowned names like Shiseido and Clé de Peau Beauté. This synergistic complement is expected to further enhance Shiseido’s position in the beauty industry.

Dr Dennis Gross Skincare was founded in 2000 by Dr Dennis Gross, a former skin cancer researcher and practicing dermatologist, along with his wife, Carrie Gross. The brand’s philosophy is deeply rooted in research, dermatology, and technology, resulting in highly effective products that cater to consumers worldwide. The acquisition now provides the brand with access to Shiseido’s global support network, commercial experience, and research and development expertise, which will accelerate its long-term growth trajectory.

For Shiseido, this acquisition offers geographic diversification and reinforces the company’s commitment to investing in the Americas region. By bringing Dr Dennis Gross Skincare into its fold, Shiseido aims to accelerate growth and increase profitability in this key market.

Masahiko Uotani, Chairman and CEO of Shiseido, expressed his excitement about the transaction, stating that it aligns with the company’s vision of becoming a personal beauty wellness company. He sees the acquisition as a way to support people in realizing their unique beauty and wellness goals throughout their lives. Uotani emphasized that the brand’s scientific and innovative approach to beauty, as well as its people-first culture, resonate with Shiseido’s core values.

Ron Gee, President and CEO of Shiseido Americas and Global M&A Leader, lauded Carrie Gross for her innovative and disruptive contributions to the beauty industry. He also highlighted Dr Dennis Gross Skincare’s commitment to delivering credible and effective products through research, accessibility, and education. Gee believes that the collaboration between Shiseido and Dr Dennis Gross Skincare will pave thway for more groundbreaking developments in the beauty industry.

Dr Dennis Gross himself expressed his confidence in Shiseido as the ideal home for his brand. He believes that the acquisition will provide Dr Dennis Gross Skincare with the necessary resources and support to continue its mission of delivering exceptional skincare solutions.

The transaction is subject to customary regulatory approvals and closing conditions and is expected to be finalized in the first quarter of the year.

Useful links: